retatrutide visceral fat Retatrutide: The Belly & Muscle Loss Truth Losing visceral fat : r/Retatrutide

Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation

In humans, once-weekly subcutaneous dual GLP-1R/GIPR agonist LY3298176 administration obtained greater weight loss and glucose control than dulaglutide, with an acceptable tolerability profile [166]

Here are the average weight loss results based on the dose and timeline: 1 mg: 7.2% in 24 weeks and 8.7% in 48 weeks 4 mg: 12.9% in 24 weeks and 16.3% in 48 weeks 8 mg: 17.3% in 24 weeks and 23.9% in 48 weeks 12 mg: 17.5% in 24 weeks and 24.2% in 48 weeks Placebo: 1.6% in 24 weeks and 2.1% in 48 weeks The retatrutide clinical trials are still ongoing, with a phase IV planned after the current phase III

Rather, any association appears to be indirect, mediated through alterations in bowel habits

That signal is transmitted via the vagus nerves to the brain, telling it to stop eating

doi: 10.1161/circulationaha.107.741645